Rental e-scooter injuries are rising in a Canadian city, and many adults who present to the emergency department have ...

Q1 2025 earnings due to losing a major Technology customer and economic concerns, despite strong revenue growth.

1 Gooderham, M.J. et al. Phase 3 results from an innovative trial design of treating plaque psoriasis involving difficult-to-treat, high-impact sites with icotrokinra, a targeted oral peptide that ...

UNLOXCYT (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma Special meeting of stockholders to vote on Merge ...

Blueprint Medicines Corporation ( NASDAQ: BPMC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET ...

Finally, random chart ... patient safety concerns reached the same conclusion.68 What's missing from these estimates are true incidence data, as typically the denominators are not available or ...

The pharmacists reviewed patients' medical charts ... The severity of the incidents was categorised as significant, serious, life-threatening or fatal using a methodology developed by the Brigham and ...

An abbreviated investigation flow chart is shown in figure 1 and an abbreviated treatment ... Factors to be taken into account include the severity and recurrent nature of the anaemia, the risk of ...

Here's Seattle's projected safety depth chart to begin the 2025 season. Note: Macdonald has stated in the past that his scheme doesn't use the typical "free safety" and "strong safety" positions.

CNH and Starlink Logos CNH expands connectivity solutions with SpaceX’s Starlink CNH's New Holland and Case IH brands' ...

Backed Solution for Nerve Pain—Natural Relief Strategies, Expert Tips, and a 365-Day Guarantee Highlighted in New In-Depth ...